![](https://webarchive.library.unt.edu/eot2008/20090514031243im_/http://www.cancer.gov/images/spacer.gif) |
|
(ih-pih-LIM-yoo-mab)
![](https://webarchive.library.unt.edu/eot2008/20090514031243im_/http://www.cancer.gov/images/spacer.gif)
| A monoclonal antibody being studied in the treatment of certain types of cancer. Ipilimumab is made in the laboratory and binds to the molecule CTLA-4 on T cells (a type of white blood cell). Ipilimumab may block CTLA-4 and help the immune system kill cancer cells. Also called MDX-010. |
Previous Definitions: | ionizing radiation, ionomycin, IORT, IP, IP6 | Next Definitions: | ipsilateral, IRB, Iressa, irinotecan, irinotecan hydrochloride |
|
![](https://webarchive.library.unt.edu/eot2008/20090514031243im_/http://www.cancer.gov/images/spacer.gif) |